InvestorsHub Logo
Followers 9
Posts 2033
Boards Moderated 0
Alias Born 08/26/2010

Re: dia76ca post# 167125

Thursday, 03/13/2014 6:14:01 PM

Thursday, March 13, 2014 6:14:01 PM

Post# of 345969
At one point she said it was between Roche and Merck. Then a Roche partnership was coming. Then there was the Pfizer buyout. And the latest was a GSK partnership. Stay tuned.

The above sounds like you are quoting most of the posters on this board.

Wouldn't be surprised if the liver data is not as good as expected. That would explain the pump up to 3 and then the short. So far the shorts have always been right. March madness is turning out to be a dud as usual.

The sad part is everyone talks about manipulation but it is really a lack of execution by pphm. The stock really wants to run as witness to the usual run ups before CC's dog and pony shows and the recent run up to over $3 as people expect a surprise announcement. Once mgmt states their status quo in CC's and webcasts, the stock goes back down. If the news is there then the price will soar as when it went above $5 before the tainted data came out. The problem to date is that it hasn't. Preclinical is not going to get it done. We were there years ago and it did nothing. We have two drugs ready for phase III trials. Time for mgmt to get her done. All imo.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News